DermTech, Inc. Profile Avatar - Palmy Investing

DermTech, Inc.

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expr…

Medical - Diagnostics & Research
US, La Jolla [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

DermTech, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

DermTech, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of DermTech, Inc..

End of DMTK's Analysis
CIK: 1651944 CUSIP: 24984K105 ISIN: US24984K1051 LEI: - UEI: -
Secondary Listings
DMTK has no secondary listings inside our databases.